×
0 0 -0.000909297567628987 -0.000909297567628987 -0.00136394635144356 -0.00386451466242332 -0.00795635371675384 -0.010911570811548
Stockreport

Challenge of two Lantus patents commences [Seeking Alpha]

SANOFI (SNY)  More Company Research Source: Seeking Alpha
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Challenge of two Lantus patents commencesThe USPTO's Patent Trial and Appeal Board (PTAB) hasinstituted inter partes review of two U.S. patents owned by Sanofi (NYSE:SNY) covering Lantus (insulin glargine injection) 100 Units/mL.The patents are being challenged by Mylan N.V. (NASDAQ:MYL) who plans to market its own version of insulin glargine. Sanofi sued Mylan for patent infringement after the latter filed a marketing application with the FDA.According to IQVIA, the U.S. market is ~$7.7B.Both stocks are up a fraction premarket.Click to subscribe to real-time analytics on MYLNow read:Premarket analyst action - healthcare » [Read more]

IMPACT SNAPSHOT EVENT TIME: SNY
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS